CN105624165B - The biomolecule detecting method of cascade amplification strategy based on self-locking aptamer probe - Google Patents
The biomolecule detecting method of cascade amplification strategy based on self-locking aptamer probe Download PDFInfo
- Publication number
- CN105624165B CN105624165B CN201610005486.7A CN201610005486A CN105624165B CN 105624165 B CN105624165 B CN 105624165B CN 201610005486 A CN201610005486 A CN 201610005486A CN 105624165 B CN105624165 B CN 105624165B
- Authority
- CN
- China
- Prior art keywords
- sequence
- aptamer
- locking
- template
- self
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108091023037 Aptamer Proteins 0.000 title claims abstract description 87
- 239000000523 sample Substances 0.000 title claims abstract description 53
- 238000000034 method Methods 0.000 title claims abstract description 25
- 230000003321 amplification Effects 0.000 title claims abstract description 24
- 238000003199 nucleic acid amplification method Methods 0.000 title claims abstract description 24
- 230000019491 signal transduction Effects 0.000 claims abstract description 21
- 238000001514 detection method Methods 0.000 claims abstract description 17
- 108091008146 restriction endonucleases Proteins 0.000 claims abstract description 17
- 238000005096 rolling process Methods 0.000 claims abstract description 8
- 238000006243 chemical reaction Methods 0.000 claims description 45
- 108010081589 Becaplermin Proteins 0.000 claims description 17
- 102000004169 proteins and genes Human genes 0.000 claims description 17
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 15
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 15
- 102000012410 DNA Ligases Human genes 0.000 claims description 10
- 108010061982 DNA Ligases Proteins 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 208000035199 Tetraploidy Diseases 0.000 claims description 9
- 239000000872 buffer Substances 0.000 claims description 9
- 108020004414 DNA Proteins 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 230000015572 biosynthetic process Effects 0.000 claims description 5
- 238000011534 incubation Methods 0.000 claims description 5
- 238000009396 hybridization Methods 0.000 claims description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 4
- 102000053602 DNA Human genes 0.000 claims description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 238000006073 displacement reaction Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 239000002126 C01EB10 - Adenosine Substances 0.000 abstract description 11
- 229960005305 adenosine Drugs 0.000 abstract description 11
- 238000011895 specific detection Methods 0.000 abstract description 5
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine group Chemical group [C@@H]1([C@H](O)[C@H](O)[C@@H](CO)O1)N1C=NC=2C(N)=NC=NC12 OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 20
- 230000000295 complement effect Effects 0.000 description 13
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 150000003384 small molecules Chemical class 0.000 description 4
- 230000001960 triggered effect Effects 0.000 description 4
- 102000004594 DNA Polymerase I Human genes 0.000 description 3
- 108010017826 DNA Polymerase I Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- JVKVZDJWDATSFD-UHFFFAOYSA-N 23-methyl-21H-porphyrin propanoic acid Chemical compound C(CC)(=O)O.C(CC)(=O)O.CN1C2=CC=C1C=C1C=CC(C=C3C=CC(=CC=4C=CC(=C2)N4)N3)=N1 JVKVZDJWDATSFD-UHFFFAOYSA-N 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- 102100037850 Interferon gamma Human genes 0.000 description 2
- 108010074328 Interferon-gamma Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 101710147059 Nicking endonuclease Proteins 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000001917 fluorescence detection Methods 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000003068 molecular probe Substances 0.000 description 2
- 238000011896 sensitive detection Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PXFBZOLANLWPMH-UHFFFAOYSA-N 16-Epiaffinine Natural products C1C(C2=CC=CC=C2N2)=C2C(=O)CC2C(=CC)CN(C)C1C2CO PXFBZOLANLWPMH-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 101000599940 Homo sapiens Interferon gamma Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 1
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 1
- 239000007984 Tris EDTA buffer Substances 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 206010054094 Tumour necrosis Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 102000043557 human IFNG Human genes 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229940027941 immunoglobulin g Drugs 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/119—Strand displacement amplification [SDA]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2531/00—Reactions of nucleic acids characterised by
- C12Q2531/10—Reactions of nucleic acids characterised by the purpose being amplify/increase the copy number of target nucleic acid
- C12Q2531/125—Rolling circle
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
- C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
The invention discloses the biomolecule detecting method of the cascade amplification strategy based on self-locking aptamer probe, which includes at least two parts:There is the aptamer sequence at 3 ' ends of specific recognition and the signal transduction sequence at 5 ' ends to object, the signal transduction sequence at the 5 ' end hybridizes with part aptamer sequence, 5 ' end stem-loop structures are formed, the signal transduction sequence at the 5 ' end includes the recognition site of nicking restriction endonuclease.The probe marriage chain replaces amplification (SDA) and double indexing type rolling circle amplification (DE-RCA) strategy, realizes protein-PDGF-BB and small molecule-adenosine hypersensitive and high specific detection, detection limit is respectively up to 3.8 × 10‑16Mol/L and 4.8 × 10‑8mol/L。
Description
Technical field
The present invention relates to a kind of nucleic acid detection technique fields, and in particular to a kind of cascade expansion based on self-locking aptamer probe
Increase highly sensitive, high specific the detection method that strategy is used for protein and small-molecule substance.
Background technique
Aptamer is a kind of artificial synthesized, short single strand oligonucleotide acid sequence, is commonly used for bio-sensing, diagnosing and treating
Equal fields.Aptamer usually has specific and compact second level or tertiary structure, has high affinity to its corresponding object
And selectivity.Compared with antibody or antibody fragment, aptamer have the characteristics that stablize, be readily synthesized and modify, object it is extensive,
Object includes albumen, small molecule, metal ion even cell etc..Therefore, aptamer has been widely used for the building of molecular probe.
Molecular probe based on aptamer mainly includes two parts:Aptamer sequence and signal sequence.Aptamer sequence can
The second level or tertiary structure being fold into, while specific recognition its object.Once aptamer sequence is in conjunction with object, letter
Number sequence can be released generation signal.However, aptamer probe is usually excessive in practical aptamer sensing system.It is theoretical
Calculate display, aptamer in unbonded object, also can occurred conformation transformation to generate interference signal influence the standard of detection
True property.In order to solve this problem, a kind of method is fixed on aptamer probe on one out-phase surface, will be extra by washing
Aptamer probe wash away.This method can effectively avoid the generation of interference signal, but the introducing of biphase interface will lead to line
Property range is limited and the joint efficiency of object, probe reduces defect.In order to avoid these problems, realize based on the equal of aptamer
It mutually detects, another method is exactly the retardance DNA molecular for introducing one section short, hybridizes it with the active part of aptamer sequence, shape
At a closed aptamer probe of retardance chain, so that the non-specific of aptamer be inhibited to fold.However, since the retardance chain is shorter
(12-15nt), the unstability of duplex structure will lead to retardance chain leakage (falling off from aptamer probe), and then cause interference with letter
Number generation.Therefore, in order to be further reduced interference signal, improve detection accuracy, construct one it is new, more stable suitable
Body probe is highly important.
Summary of the invention
The present invention is to solve above-mentioned the deficiencies in the prior art, provide a kind of detection protein and biological micromolecule substance from
Locking-type aptamer probe and cascade amplification strategy based on self-locking aptamer probe for protein and small-molecule substance it is highly sensitive,
The detection method of high specific.
The technical solution adopted by the present invention is as follows:
A kind of self-locking aptamer probe for detecting protein and biological micromolecule, the probe include at least two portions
Point:There is the aptamer sequence at 3 ' ends of specific recognition and the signal transduction sequence at 5 ' ends, the signal at the 5 ' end to object
Transduction sequence hybridizes with part aptamer sequence, forms 5 ' end stem-loop structures, the signal transduction sequence at the 5 ' end includes in nicking
The recognition site of enzyme cutting, the recognition site of the nicking restriction endonuclease are located at 3 ' ends of the signal transduction sequence at 5 ' ends.
The design is so that self-locking aptamer probe is in self-locking state in no object, to make aptamer sequence in no mesh
It is not folded when marking object.Self-locking aptamer probe molecule keeps the signal transduction sequence at 5 ' ends and part suitable by folded back on itself
Complementary base-pair meets in body sequence, is formed made of Hydrogenbond, referred to as hairpin structure (or stem-loop structure).
The aptamer sequence at the 3 ' end is for combining target object, it is the Fas lignand system evolution technology by index concentration
What (abbreviation SELEX technology) repeated screening from the random oligonucleotide sequences library synthesized outside prosthesis obtained can be with high affine
The segment oligonucleotide sequence of power and specificity in conjunction with object.
The self-locking aptamer probe that the present invention designs can be used to detect various bioprotein molecules and biological micromolecule, institute
Stating bioprotein molecule is platelet-derived growth factor-BB (PDGF-BB), and biological micromolecule is adenosine.By changing aptamer sequence
Column and design probe, this method may be alternatively used for the detection of other biomolecule.
It preferably, should when the base of 5 ' end of aptamer sequence is not suitable for forming hydrogen bond with 3 ' end of signal transduction sequence
Probe further includes the catenation sequence for connecting aptamer sequence and signal transduction sequence, and the catenation sequence is used to participate in formation 5 '
Stem-loop structure is held, guarantees that signal transduction sequence can hybridize to form stem-loop structure with part aptamer sequence.
Preferably, which is also connected with cooperation sequence, the alkali of the cooperation sequence in 3 ' ends of the aptamer sequence at 3 ' ends
Base number is 1~5, it is therefore an objective to the hairpin structure for holding 3 ' end aptamer sequence smooth openings 5 '.
The present invention also provides a kind of application of above-mentioned probe in detection protein and biological micromolecule content of material.
The method of cascade amplification strategy detection protein or biological micromolecule substance based on self-locking aptamer probe, including
Following steps:
(1) chain replaces amplified reaction:First by the object to be detected containing object in conjunction with self-locking aptamer probe, fold
At three-dimensional helical structure, opens 5 ' end signal transduction sequences and the stem-loop structure of aptamer sequence formation is held in part 3 ';Above-mentioned system
In the presence of archaeal dna polymerase, nicking restriction endonuclease and dNTP, the three-dimensional helical structure at 3 ' ends is generated as primer triggering SDA reaction
A large amount of primer sequence 1;
(2) double indexing type expands rolling circle amplification:Primer sequence 1 in step (1) is hybridized with template 1, in archaeal dna polymerase
Under the action of trigger first order exponential type RCA amplified reaction, generate a large amount of primer sequence 2;Primer sequence 2 hybridizes with template 2,
Exponential type RCA amplified reaction in the second level is triggered under the action of archaeal dna polymerase, generates a large amount of G- tetraploid sequence, is inserted into glimmering
After optical molecule, fluorescence signal is generated, quantitative survey is carried out to protein or biological micromolecule substance by the fluorescence signal detected
It is fixed.
Specific step is as follows:Primer sequence 1 hybridizes with template 1, and linear RCA reaction is triggered under the action of archaeal dna polymerase,
Generate a long single-stranded DNA product;The product can hybridize with template 1 excessive in system, expose nicking restriction endonuclease
Recognition site, to generate a large amount of primer sequence 2 by nicking enzyme restriction endonuclease nicking;And free 1/ template of primer, 1 compound
Next polymerization, nicking circulation are carried out, first order exponential type RCA amplified reaction is completed;Finally, primer sequence 2 and template 2 are miscellaneous
It hands over, exponential type RCA amplified reaction in the second level is triggered under the action of archaeal dna polymerase, generates a large amount of G- tetraploid sequence, be inserted into
After fluorescent molecule, fluorescence signal is generated by the fluorescence signal detected, quantitative survey is carried out to protein or biological micromolecule substance
It is fixed.
If do not contain object in object to be detected, chain does not occur and replaces amplified reaction and double indexing type amplification rolling ring
Amplified reaction does not generate fluorescence signal then after being inserted into fluorescent molecule.
Specifically include following steps:
(1) chain of binding induction replaces amplification (SDA)
Object to be detected containing object and above-mentioned self-locking aptamer probe are subjected to first time incubation reaction, after incubation
The archaeal dna polymerase with strand-displacement activity, nicking restriction endonuclease, dNTPs, buffer and water is added and carries out second of incubation reaction,
Make SDA reaction terminating finally by heating;Specific reaction step is as follows:
Object and self-locking aptamer probe to be detected (50nM, 5 μ L) containing object is incubated for 1h at 37 DEG C;Then add
Enter 0.4 μ L KF polymerase, 0.2 μ L Nt.BbvCI, 4 μ L 2mM dNTPs, 2 μ L Cutsmart and 3.4 μ L water, is incubated at 37 DEG C
Educate 2.5h;Make SDA reaction terminating finally by 80 DEG C of heating 10min.
(2) connection reaction
Addition template 1 in amplified production in step (1), T4DNA ligase, T4DNA ligase buffer solution and water, into
The reaction of 1 loop connecting of row template;Specific reaction step is as follows:
1.4 μ L, 10 μM of templates 1,0.3 μ L T4 DNA ligase, 3.0 μ L are added into above-mentioned 20 μ L SDA amplified production
T4 DNA ligase buffer and 5.3 μ L water react 40min at 37 DEG C.
(3) double indexing type rolling circle amplification (DE-RCA)
Take the connection product in step (2), be added template 2, archaeal dna polymerase, nicking restriction endonuclease, buffer and dNTPs and
Water carries out amplification reaction, and makes DE-RCA reaction terminating finally by heating;Specific reaction step is as follows:
Above-mentioned 30 μ L connection reaction product is taken, 1.4 μ L, 10 μM of templates 2,0.4 μ L phi 29DNA polymerase, 0.4 μ are added
LNt.BbvCI, 5 μ L Cutsmart, 10 μ L dNTPs and 22.8 μ L water react 5h at 37 DEG C;Step reaction passes through 80 DEG C of heating
10min is terminated.
(4) fluorescence detection
The amplified production in step (3) is taken, N- methyl porphyrin dipropionic acid IX (NMM) is added and is reacted, finally using glimmering
Light instrument carries out fluoremetry;Specific reaction step is as follows:
It takes above-mentioned DE-RCA product, 5 μ L 2mM KCl and 5 μ L 0.08mM NMM is added, react 40min at 37 DEG C.Finally
Fluoremetry is carried out with Hitachi F-7000 luminoscope, excitation wavelength selects 399nm, the capture range selection of launch wavelength
Fluorescence intensity at 550~680nm, final choice 612nm investigates the sensitivity of method.
Preferably, the signal transduction sequence such as SEQ ID No at the 5 ' end:Shown in 1.
Preferably, the signal transduction sequence at the 5 ' end is 5 '-GCT GTG GAT ACT GCT GAG GCC A-3 ', such as
SEQ ID No:Shown in 1.
It is different according to the object of detection, replace corresponding 3 ' end aptamer sequence and catenation sequence.When object is and cancer
When relevant platelet derived growth factor BB (PDGF-BB) of disease, it is preferred that the aptamer sequence of PDGF-BB is 5 '-CA GGC TAC
GGC ACG TAG AGC ATC ACC ATG ATC CTG-3 ', such as SEQ ID No:Shown in 2, catenation sequence 5 '-CCA-3 ',
Cooperation sequence is 5 '-TG-3 '.When object is adenosine, it is preferred that the aptamer sequence of adenosine is 5 '-AC CTG GGG GAG
TAT TGC GGA GGA AGG T-3 ', such as SEQ ID No:Shown in 3, catenation sequence 5 '-CCACAG-3 ', cooperation sequence be
5’-CTGT-3’。
Preferably, the nicking restriction endonuclease is nicking enzyme Et.BbvCI, the recognition site of corresponding nicking enzyme Et.BbvCI
Sequence is 5 '-GCT GAG G-3 '.
Preferably, the sequence of the template 1, which is formed, includes the complementary series of one section of primer sequence 1 after ring-type and draws with two
The complementary series of object sequence 2, between the complementary series of each primer sequence 2, the complementary series of primer sequence 2 and primer sequence 1
Complementary series between be connected by nicking endonuclease recognized site sequence.Preferably 5 '-TAC TGC TGA GGG AGT
TGA GTG CTG AGG GAG TTG AGT GCT GAG GCT GTG GA-3 ', such as SEQ ID No:Shown in 4, wherein crossing
Sequence is the recognition site of nicking restriction endonuclease.Wherein, the primer sequence 1 is the product of above-mentioned SDA reaction, the primer sequence
2 be the product of above-mentioned first order exponential type RCA amplified reaction.
Preferably, the sequence of the template 2 forms complementary series and two G- tetra- including one section of primer sequence 2 after ring-type
The complementary series of times body sequence, between each G- tetraploid complement thereof, the complementary series and primer of G- tetraploid sequence
It is connected by nicking endonuclease recognized site sequence between the complementary series of sequence 2.Preferably 5 '-AGTGCT GAG
GAA ACC CAA CCC GCC CTA CCC GCT GAG GAA ACC CAA CCC GCC CTA CCC GCT GAG GGA
GTT G-3 ', such as SEQ ID No:Shown in 5, wherein drawing the complementary series that single line sequence is G- tetraploid, drawing two-wire sequence is to cut
Carve the recognition site of restriction endonuclease.
Preferably, the fluorescent molecule is NMM (N- methyl porphyrin dipropionic acid IX).
Preferably, the archaeal dna polymerase used in the SDA reaction is the archaeal dna polymerase with strand-displacement activity, such as
Klenow Fragment polymerase.
Preferably, the archaeal dna polymerase used in rolling circle amplification reaction is phi 29DNA polymerase.
The present invention also provides a kind of kits for detecting protein and biological micromolecule substance, including:
(1) self-locking aptamer probe according to any one of claims 1 to 3;
(2) archaeal dna polymerase, nicking restriction endonuclease, T4DNA ligase;
(3) dNTPs, fluorescent molecule and KCl solution;
(4) buffer of Cutsmart buffer, T4DNA ligase;
(5) above-mentioned template 1 and template 2.
Preferably, the archaeal dna polymerase includes Klenow Fragment polymerase and phi 29DNA polymerase.
The beneficial effects of the invention are as follows:
The present invention constructs a self-locking aptamer probe.The probe has triple functions:First is that based on its 3 ' end aptamer
The molecular recognition function of sequence;Second is that being based on the signal transduction functionality of its 5 ' terminal signal sequence;Third is that based on signal sequence and fitting
The self-locking function of body sequence hybridization.Since signal sequence is intramolecular hybridization with hybridizing for aptamer sequence, so this self-locking
Aptamer probe is stablized than the aptamer probe of retardance chain retardance, therefore is more conducive to reducing the folding of aptamer non-specificity and interference
Signal.In addition, the expansion of the cascade based on the self-locking aptamer probe has also been devised in the present invention for the sensitivity of ensuring method
Increasing strategy, realizes the highly sensitive and high specific detection of platelet derived growth factor BB (PDGF-BB), detection limits up to 3.8 ×
10-16Mol/L, the range of linearity are more than 6 orders of magnitude.By changing aptamer sequence, which is also employed successfully in small molecule-gland
The Sensitive Detection of glycosides illustrates that the self-locking aptamer probe has good versatility, has at the actually detected aspect of biomolecule
There is very big application potential.
The present invention reacts the strategy combined with SDA reaction and DE-RCA using self-locking aptamer probe, realizes biological egg
High sensitivity and the high specific detection of white molecule and biological micromolecule substance.
Detailed description of the invention
Fig. 1:The cascade amplification strategy that self-locking aptamer probe mediates is used for sensitive, specific detection the principle of protein
Figure.
Fig. 2 (A):The fluorogram spectrogram of various concentration PDGF-BB;Wherein, a → l is followed successively by blank, 2 × 10-15M、5×
10-15M、1×10-14M、1×10-13M、1×10-12M、1×10-11M、1×10-10M、1×10-9M、1×10-8M、2.0×10- 8M、5×10-8M。
Fig. 2 (B):The linear relationship chart of fluorescence intensity and PDGF-BB concentration.
Fig. 3:The specificity of method investigates schematic diagram.
Fig. 4 (A):Adenosine detection principle diagram.
Fig. 4 (B):The fluorescence response figure of various concentration adenosine;Wherein, a → i is followed successively by blank, 1 × 10-7M、5×10- 7M、1×10-6M、5×10-6M、1×10-5M、5×10-5M、8×10-5M、1×10-4M。
Fig. 4 (C):The linear relationship chart of various concentration adenosine and fluorescence intensity.
Specific embodiment
Embodiment 1
1. experimental section
1.1 reagents and material
DNA (sequence such as table 1) used and dNTPs are by Sheng Gong bioengineering Co., Ltd (China, Shanghai) synthesis in experiment
And purifying;Platelet derived growth factor (PDGF-BB), immunoglobulin G (Ig G), huamn tumor necrosis factory alpha (TNF-α),
Human interferon gamma (IFN-γ) and fibrin ferment are purchased from ProSpec-Tany company (Nai Siciaona, Israel);Adenosine is purchased from
Sigma-Aldrich company (St. Louis, the U.S.);Klenow Fragment polymerase, nicking enzyme Et.BbvCI, T4DNA connect
Enzyme and 29 archaeal dna polymerase of phi are connect purchased from New England Biolabs company (U.S.);NMM is purchased from J&K Scientific
Company (Beijing, China);Other reagents (analysis is pure) are purchased from standard suppliers.
HEPES buffer solution used includes 50mM NaCl and 25mM HEPES (pH 7.0) in experimentation;PBS buffer solution
Include 0.15M NaCl, 2.4mM NaH2PO4With 7.6mM Na2HPO4(PH 7.4);TE buffer include 10mM Tris and
1.0mM Na2EDTA(PH 8.0)。
DNA sequence dna used in the experiment of table 1
Note:Double-crossed sequence is PDGF-BB aptamer sequence difference, the aptamer sequence of chain-dotted line sequence adenosine;Single scribing line sequence
Nicking enzyme Et.BbvCI recognition site, wave sequence are the complementary series of G- tetraploid.
The chain of 1.2 binding inductions replaces amplification (SDA)
PDGD-BB (10nM, 5 μ L) and self-locking aptamer probe (50nM, 5 μ L) are incubated for 1h at 37 DEG C.Then it is added
0.4 μ L KF polymerase, 0.2 μ L Nt.BbvCI, 4 μ L 2mM dNTPs, 2 μ L Cutsmart and 3.4 μ L water are incubated at 37 DEG C
2.5h.Make SDA reaction terminating finally by 80 DEG C of heating 10min.
1.3 connection reactions
1.4 μ L, 10 μM of templates 1,0.3 μ L T4 DNA ligase, 3.0 μ L T4 are added into above-mentioned 20 μ L SDA product
DNA ligase buffer and 5.3 μ L water react 40min at 37 DEG C.
1.4 double indexing type rolling circle amplifications (DE-RCA)
Above-mentioned 30 μ L connection reaction product is taken, 1.4 μ L, 10 μM of templates 2,0.4 μ L phi, 29 polymerase, 0.4 μ are added
LNt.BbvCI, 5 μ L Cutsmart, 10 μ L dNTPs and 22.8 μ L water react 5h at 37 DEG C.Step reaction passes through 80 DEG C of heating
10min is terminated.
1.5 fluorescence detection
It takes above-mentioned DE-RCA product, 5 μ L 2mM KCl and 5 μ L 0.08mM NMM is added, react 40min at 37 DEG C.Finally
Fluoremetry is carried out with Hitachi F-7000 luminoscope, excitation wavelength selects 399nm, the capture range selection of launch wavelength
Fluorescence intensity at 550~680nm, final choice 612nm investigates the sensitivity of method.
2. results and discussion
2.1 principle
Such as Fig. 1, designs first and construct a self-locking aptamer probe.The probe includes two parts:The aptamer at 3 ' ends
The signal transduction sequence of sequence and 5 ' ends.In addition, the signal transduction sequence can hybridize with aptamer Sequence, make probe in nothing
Self-locking state is in when object, from without folding, the low background of ensuring method.In this method, select cancer relevant
PDGF-BB is as model analysis object.In the presence of having PDGF-BB in system, aptamer probe is folded into three in conjunction with PDGF-BB
To helical structure, the hairpin structure at 5 ' ends is opened.Next, in the presence of KF polymerase, nicking enzyme Et.BbvCI and dNTP, 3 '
The three-dimensional helical structure at end generates a large amount of primer 1 as primer triggering SDA reaction.Then, primer 1 and 1 Eclectics of template,
Linear RCA reaction is triggered under the action of 29 polymerase of phi, generates a long single-stranded DNA product.The product can be with system
In excessive template 1 hybridize, expose the recognition site of nicking enzyme, to be carved by nicking digestion, generate a large amount of primer 2.And
Free 1/ template of primer, 1 compound have can carry out it is next polymerization, nicking circulation, complete the first order exponential type RCA amplification.Most
Afterwards, primer 2 hybridizes with template 2, and triggering second level exponential amplification reaction generates a large amount of G- tetraploid sequence, after being inserted into NMM,
Generate the fluorescence signal of enhancing.
2.2 condition optimizing
It is dense to SDA reaction time, DE-RCA reaction time, the polymerization of phi 29 enzyme dosage, Et.BbvCI dosage and NMM respectively
Degree is optimized.The final choice SDA time be 2.5h, DE-RCA reaction time be 5h, phi 29 polymerize enzyme dosage be 4U,
Et.BbvCI dosage is final concentration of 5 μM of 4U, NMM.
2.3 sensitivity are investigated
In optimal conditions, the sensitivity of method is investigated, such as Fig. 2,2.0 × 10-15Mol/L~1.0 ×
10-8Within the scope of mol/L, the linear relationship of fluorescence intensity and target concentration is good, and linear equation is Δ F=2548.4+
713.0lgC, detection are limited to 3.8 × 10-16mol/L。
2.4 specificity are investigated
Using Ig G, TNF-α, IFN-γ and fibrin ferment as jamming target object, the specificity of method is investigated.Such as figure
3, this method only has strong fluorescence response to PDGF-BB, to the fluorescence response very little of other albumen, illustrates that this method has very
Good specificity.
2.5 versatilities are investigated
In order to investigate the versatility of method, the aptamer part of probe is replaced with to the aptamer sequence of adenosine, is realized to gland
The Sensitive Detection of glycosides.Such as Fig. 4, method is 1.0 × 10-7Mol/L~1.0 × 10-4Within the scope of mol/L, fluorescence intensity is dense with adenosine
The linear relationship of degree is good, and detection is limited to 4.8 × 10-8mol/L。
In addition, the aptamer sequence of probe to be changed to the aptamer sequence of other biomolecule, it can also be carried out highly sensitive
It spends and detects with high specificity.
3. summarizing
In this work, the present invention constructs a self-locking aptamer probe, expands in conjunction with the cascade of SDA and DE-RCA,
Protein and the highly sensitive of small molecule, high specific detection are realized, detection limit is respectively up to 3.8 × 10-16Mol/L and 4.8 ×
10-8mol/L。
Bibliography:
(a)A.D.Ellington and J.W.Szostak,Nature,1990,346,818;(b)A.B.Iliuk,
L.Hu and W.A.Tao,Anal.Chem.,2011,83,4440;(c)H.Sun and Y.Zu,Molecules,2015,20,
11959.
(a)K.A.Davis,B.Abrams,Y.Lin and S.D.Jayasena,Nucleic acids Res.,1996,
24,702;(b)H.M.So,K.Won,Y.H.Kim,B.K.Kin,B.H.Ryu,P.S.Na,H.Kim and J.O.Lee,
J.Am.Chem.Soc.,2005,127,11906;(c)C.J.Yang,S.Jockusch,M.Vicens,N.J.Turro and
W.Tan,Proc.Natl.Acad.Sci.,2005,102,17278.
H.Li,W.Qiang,M.Vuki,D.Xu and H.Y.Chen,Anal.Chem.,2011,83,8945.
(a)W.Zhao,W.Chiuman,J.C.F.Lam,S.A.McManus,W.Chen,Y.Cui,R.Pelton,
M.A.Brook and Y.Li,J.Am.Chem.Soc.,2008,130,3610;(b)J.Liu and Y.Lu,
Angew.Chem.Int.Ed.,2006,45,90;(c)M.N.Stojanovic,P.Prada and D.W.Landry,
J.Am.Chem.Soc.,2000,122,11547.
(a)H.Ueyama,M.Takagi and S.Takenaka,J.Am.Chem.Soc.,2002,124,14286;(b)
B.Kim,I.H.Jung,M.Kang,H.K.Shim and H.Y.Woo,J.Am.Chem.Soc.,2012,134,3133.
(a)J.Yin,X.He,K.Wang,Z.Qing,X.Wu,H.Shi and X.Yang,Nanoscale,2012,4,
110;(b)Y.Xhu,P.Chandra and Y.B.Shim,Anal.Chem.,2013,85,1058.
(a)L.Xue,X.Zhou and D.Xing,Anal.Chem.,2012,84,3507;(b)W.Zhou,X.Gong,
Y.Xiang,R.Yuan and Y.Chai,Anal.Chem.,2014,86,953;D.W.Zhang,J.Nie,F.T.Zhang,
L.Xu,Y.L.Zhou and X.X.Zhang,Anal.Chem.,2013,85,9378.
(a)H.Shi,X.He,K.Wang,X.Wu,X.Ye,Q.Guo,W.Tan,Z.Qing,X.Yang and B.Zhou,
Proc.Natl.Acad.Sci.,2011,108,3900;(b)J.Yin,X.He,K.Wang,F.Xu,J.Shangguan,D.He
and H.Shi,Anal.Chem.,2013,85,12011.
M.Zuker,Nucleic Acids Res.,2003,31,3406.
(a)L.Zhou,L.J.Ou,X.Chu,G.L.Shen and R.Q.Yu,Anal.Chem.,2007,79,7492;
(b)W.Song,K.Zhu,Z.Cao,C.Lau and J.Lu,Analyst,2012,137,1796;(c)L.Tang,Y.Liu,
M.M.Ali,D.K.Kang,W.Zhao and J.Li,Anal.Chem.,2012,84,4711;(d)J.Sun,W.Jiang,
J.Zhu,W.Li and L.Wang,Biosens.Bioelectron.,2015,70,15.
(a)K.N.Baker,M.H.Rendall,A.Patel,P.Boyd,M.Hoare,R.B.Freedman and
D.C.James,Trends Biotechnol.,2002,20,149;(b)A.Greystoke,J.Cummings,T.Ward,
K.Simpson,A.Renehan,F.Butt,D.Moore,J.Gietema,F.Blackhall,M.Ranson,A.Hughes
and C.Dive,Ann.Oncol.,2008,19,990.
(a)R.Levicky,T.M.Herne,M.J.Tarlov and S.K.Satija,J.Am.Chem.Soc.,1998,
120,9787;(b)E.L.S.Wong,E.Chow and J.J.Gooding,Langmuir,2005,21,6957;(c)H.Pei,
N.Lu,Y.Wen,S.Song,Y.Liu,H.Yan and C.Fan,Adv.Mater.,2010,22,4754.
(a)B.Shlyhovsky,D.Li,Y.Weizmann,R.Nowarski,M.Kotler and I.Willner,
J.Am.Chem.Soc.,2007,129,3814;(b)B.Fu,J.Cao,W.Jiang ang L.Wang,
Biosens.Bioelectron.,2013,44,52;(c)C.Feng,J.Zhu,J.Sun,W.Jiang and L.Wang,
Talanta,2015,143,101.
(a)Z.Zhang and C.Zhang,Anal.Chem.,2012,84,1623;(b)H.Zhang,F.Li,
H.Chen,Y.Ma,S.Qi,X.Chen and L.Zhou,Sensors and Actuators B,2015,207,784.
Claims (4)
1. the method for the cascade amplification strategy detection protein based on self-locking aptamer probe, characterized in that the method is used for
Non-treatment and non-diagnostic purpose, include the following steps:
(1) chain replaces amplified reaction:By the object to be detected containing object in conjunction with self-locking aptamer probe, it is folded into three-dimensional spiral shell
Structure is revolved, 5 ' end signal transduction sequences is opened and the stem-loop structure of aptamer sequence formation is held in part 3 ';Above-mentioned system is poly- in DNA
In the presence of synthase, nicking restriction endonuclease and dNTP, chain occurs and replaces amplified reaction, generates a large amount of primer sequence 1;
(2) double indexing type expands rolling circle amplification:Primer sequence 1 in step (1) is hybridized with template 1, triggers first order index
Type RCA amplified reaction generates a large amount of primer sequence 2;Primer sequence 2 hybridizes with template 2, and triggering second level exponential type RCA expands
Increase reaction, generate a large amount of G- tetraploid sequence, after being inserted into fluorescent molecule, generates fluorescence signal and pass through the fluorescence signal detected
Protein or biological micromolecule are quantitative determined;
If do not contain object in object to be detected, chain does not occur and replaces amplified reaction and double indexing type amplification rolling circle amplification
Reaction, then without fluorescence signal;
The object is protein;The protein is platelet derived growth factor BB;
The self-locking aptamer probe includes at least two parts:There is the aptamer sequence at 3 ' ends of specific recognition to object
The signal transduction sequence of the signal transduction sequence of column and 5 ' ends, the 5 ' end hybridizes with part aptamer sequence, forms 5 ' end stem-loops
The signal transduction sequence of structure, the 5 ' end includes the recognition site of nicking restriction endonuclease;The self-locking aptamer probe is also wrapped
The catenation sequence for connecting aptamer sequence and signal transduction sequence is included, the catenation sequence is used to participate in formation 5 ' and holds stem-loop
Structure;Aptamer sequence of the self-locking aptamer probe at 3 ' ends is also connected with cooperation sequence;
The self-locking aptamer probe is the self-locking aptamer probe of platelet derived growth factor BB, sequence:GCT GTG GAT
ACT GCT GAG GCC ACA GGC TAC GGCACG TAG AGC ATC ACC ATG ATC CTG TG, such as SEQ ID
No:Shown in 6;
1 nucleotides sequence of template is classified as:TAC TGC TGA GGG AGT TGA GTG CTG AGG GAG TTGAGT GCT
GAG GCT GTG GA, such as SEQ ID No:Shown in 4;2 nucleotides sequence of template is classified as:AGT GCT GAG GAA ACC
CAA CCC GCC CTA CCC GCTGAG GAA ACC CAA CCC GCC CTA CCC GCT GAG GGAGTT G, such as SEQ
ID No:Shown in 5.
2. the method as described in claim 1, characterized in that in step (1), SDA react the step of be:Object will be contained
Object and self-locking aptamer probe to be detected carries out first time incubation reaction, and being added after being incubated for has the DNA of strand-displacement activity poly-
Synthase, nicking restriction endonuclease, dNTPs, buffer and water carry out second of incubation reaction, make SDA reaction terminating finally by heating.
3. the method as described in claim 1, characterized in that specific reaction step is in step (2):Primer sequence 1 and template 1
Hybridization triggers linear RCA reaction under the action of archaeal dna polymerase, generates a long single-stranded DNA product;The product and template 1
Hybridization, exposes the recognition site of nicking restriction endonuclease, to generate a large amount of primer sequence 2 by nicking restriction endonuclease nicking;And it swims
From 1/ template of primer, 1 compound carry out it is next polymerization, nicking circulation, complete the first order exponential type RCA amplification;Finally, drawing
Object sequence 2 hybridizes with template 2, and triggering second level exponential amplification reaction generates a large amount of G- tetraploid sequence, is inserted into fluorescent molecule
Afterwards, fluorescence signal is generated to quantitative determine protein or biological micromolecule by the fluorescence signal detected.
4. a kind of kit for detecting protein, characterized in that the kit includes:(1) self-locking aptamer probe;It is described from
Locking-type aptamer probe sequence:GCT GTG GAT ACT GCT GAG GCC ACA GGC TAC GGCACG TAG AGC ATC
ACC ATG ATC CTG TG, such as SEQ ID No:Shown in 6;
(2) archaeal dna polymerase, nicking restriction endonuclease, T4DNA ligase;
(3) dNTPs, fluorescent molecule and KCl solution;
(4) buffer of Cutsmart buffer, T4DNA ligase;
(5) template 1 and template 2;
1 nucleotides sequence of template is classified as:TAC TGC TGA GGG AGT TGA GTG CTG AGG GAG TTGAGT GCT
GAG GCT GTG GA, such as SEQ ID No:Shown in 4;2 nucleotides sequence of template is classified as:AGT GCT GAG GAA ACC
CAA CCC GCC CTA CCC GCTGAG GAA ACC CAA CCC GCC CTA CCC GCT GAG GGAGTT G, such as SEQ
ID No:Shown in 5.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610005486.7A CN105624165B (en) | 2016-01-05 | 2016-01-05 | The biomolecule detecting method of cascade amplification strategy based on self-locking aptamer probe |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610005486.7A CN105624165B (en) | 2016-01-05 | 2016-01-05 | The biomolecule detecting method of cascade amplification strategy based on self-locking aptamer probe |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105624165A CN105624165A (en) | 2016-06-01 |
CN105624165B true CN105624165B (en) | 2018-11-30 |
Family
ID=56039510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610005486.7A Expired - Fee Related CN105624165B (en) | 2016-01-05 | 2016-01-05 | The biomolecule detecting method of cascade amplification strategy based on self-locking aptamer probe |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105624165B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105950755B (en) * | 2016-06-17 | 2020-05-08 | 山东大学 | Method for detecting microRNA based on split recognition mode combined with cascade signal amplification strategy |
CN106048024B (en) * | 2016-06-17 | 2020-03-31 | 山东大学 | Method for detecting adenosine by constructing fluorescence signal amplification biosensing platform based on target object induced proximity binding |
CN106222251B (en) * | 2016-07-21 | 2019-12-13 | 山东大学 | method for detecting transcription factor based on co-localization recognition activated cascade signal amplification strategy |
CN107267499B (en) * | 2017-06-22 | 2020-09-04 | 中国海洋大学 | Method for preparing circular DNA or RNA |
CN107884565B (en) * | 2017-10-13 | 2019-12-24 | 广东省生态环境技术研究所 | Detection method and detection kit for arsenic ions |
CN108646014B (en) * | 2018-05-21 | 2020-07-17 | 青岛大学 | Method for fluorescence detection of platelet-derived growth factor based on aptamer conformational change |
TW202039838A (en) * | 2018-12-28 | 2020-11-01 | 大陸商江蘇金斯瑞生物科技有限公司 | A method for synthesizing single-stranded dna |
CN111286503B (en) * | 2020-03-13 | 2023-10-20 | 南方医科大学 | Aptamer and application thereof in PDGF-BB detection kit |
CN113624980B (en) * | 2021-08-09 | 2023-06-13 | 四川大学华西医院 | Method and kit for detecting protein based on identification induction isothermal amplification technology |
CN114410601A (en) * | 2021-12-24 | 2022-04-29 | 山东大学 | Enzyme-embedded ZIF-8/DNA nano composite probe and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103436608A (en) * | 2013-08-08 | 2013-12-11 | 中国科学院广州生物医药与健康研究院 | Rapid detection method based on nucleic acid aptamers and kit |
CN104711347A (en) * | 2015-03-09 | 2015-06-17 | 山东大学 | Label-free fluorescence aptamer sensor detection adenosine based on double-amplification strategy construction |
CN104789674A (en) * | 2015-04-14 | 2015-07-22 | 江苏省原子医学研究所 | Probe based on double-signal amplification triggered by target and application of probe |
-
2016
- 2016-01-05 CN CN201610005486.7A patent/CN105624165B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103436608A (en) * | 2013-08-08 | 2013-12-11 | 中国科学院广州生物医药与健康研究院 | Rapid detection method based on nucleic acid aptamers and kit |
CN104711347A (en) * | 2015-03-09 | 2015-06-17 | 山东大学 | Label-free fluorescence aptamer sensor detection adenosine based on double-amplification strategy construction |
CN104789674A (en) * | 2015-04-14 | 2015-07-22 | 江苏省原子医学研究所 | Probe based on double-signal amplification triggered by target and application of probe |
Non-Patent Citations (4)
Title |
---|
Highly Sensitive and Homogeneous Detection of Membrane Protein on a Single Living Cell by Aptamer and Nicking Enzyme Assisted Signal Amplification Based on Microfluidic Droplets;Lu Li et al.;《Anal.Chem.》;20140429;5101-5107 * |
Highly Sensitive and Selective Bifunctional Oligonucleotide Probe for Homogeneous Parallel Fluorescence Detection of Protein and Nucleotide Sequence;Li-Ping Qiu et al.;《Anal.Chem.》;20110329;3050-3057 * |
Highly Sensitive Detection of Protein with Aptamer-Based Target-Triggering Two-Stage Amplification;Zhen-zhu Zhang and Chun-yang Zhang;《Anal.Chem.》;20120108;1623-1629 * |
基于适配体和酶辅助的荧光信号放大进行膜蛋白的高灵敏均相检测;王倩;《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》;20140815;B014-496 * |
Also Published As
Publication number | Publication date |
---|---|
CN105624165A (en) | 2016-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105624165B (en) | The biomolecule detecting method of cascade amplification strategy based on self-locking aptamer probe | |
ES2385341T3 (en) | Detection of electrocatalytic nucleic acid hybridization | |
JP3892450B2 (en) | Liquid phase nucleic acid sandwich assay with reduced background noise | |
JPH03501211A (en) | Methods and reagents for detecting nucleic acid base sequences | |
CN106939344B (en) | Linker for next generation sequencing | |
CN109536579A (en) | The construction method of single-stranded sequencing library and its application | |
Ren et al. | Versatile G-quadruplex-mediated strategies in label-free biosensors and logic systems | |
AU2014409073A1 (en) | Linker element and method of using same to construct sequencing library | |
CN113512578B (en) | miRNA chemiluminescence detection kit based on constant-temperature enzyme-free multistage amplification | |
Ma et al. | A tutorial review for employing enzymes for the construction of G-quadruplex-based sensing platforms | |
Fox et al. | An extra dimension in nucleic acid sequence recognition | |
Lu et al. | A dual-functional fluorescent biosensor based on enzyme-involved catalytic hairpin assembly for the detection of APE1 and miRNA-21 | |
JP4616881B2 (en) | Assist probe and method of using the same | |
Hu et al. | Combining cooperativity with sequestration: a novel strategy for discrimination of single nucleotide variants | |
Li et al. | Ultrasensitive DNA detection by cycle isothermal amplification based on nicking endonuclease and its application to logic gates | |
Xue et al. | Highly sensitive protein detection based on aptamer probe and isothermal nicking enzyme assisted fluorescence signal amplification | |
CN107958139A (en) | A kind of computer coding method of nucleotide double for DNA encoding library of compounds | |
CN105452488B (en) | Compositions and methods for detecting HEV nucleic acids | |
JP7281565B2 (en) | Nested multiplex PCR high-throughput sequencing library preparation method and kit | |
CN107988320A (en) | A kind of molecular label connector and its preparation method and application | |
WO2004085680A1 (en) | Method of detecting target nucleotide sequence, detection target structure to be used in embodying the method, process for producing the same and assay kit for detecting target nucleotide sequence | |
Li et al. | Isothermal cross-boosting extension–nicking reaction mediated exponential signal amplification for ultrasensitive detection of polynucleotide kinase | |
JP2023511228A (en) | Luminescent hybridization assay method | |
CN107406879A (en) | The detection method of genetic mutation and the fluorescence labeling oligonucleotides used wherein | |
US7026120B2 (en) | Probes for detecting tumor cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181130 |